tesmilifene has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Falus, A; Hegyesi, H; Hunyadi, J; Juhász, I; Kovács, P; Lázár-Molnár, E; Martin, G; Rivera, E; Szincsák, N | 1 |
Robinson, A | 1 |
2 other study(ies) available for tesmilifene and B16 Melanoma
Article | Year |
---|---|
Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autocrine Communication; Cell Division; Cimetidine; Cytochrome P-450 Enzyme System; Drug Synergism; Histamine H2 Antagonists; Histidine Decarboxylase; Humans; Interferon-gamma; Macrophages; Melanoma; Melanoma, Experimental; Mice; Mice, SCID; Neoplasm Proteins; Phenyl Ethers; Receptors, Histamine H2; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
More questions than answers: antihistamines' link to cancer.
Topics: Animals; Astemizole; Canada; Dose-Response Relationship, Drug; Drug Industry; Fibrosarcoma; Histamine Antagonists; Histamine H1 Antagonists; Hydroxyzine; Loratadine; Melanoma, Experimental; Mice; Phenyl Ethers; Tamoxifen; United States; United States Food and Drug Administration | 1994 |